Alymsys

Common Brands Alymsys
Drug Class
Vascular endothelial growth factor (VEGF) inhibitor
Controlled Substance Classification
Not a controlled medication
Generic Status
No Lower-cost generic available
Availability
Prescription only
Kristianne Hannemann, PharmD
Kristianne Hannemann, PharmD
Read More
Medically reviewed by Kristianne Hannemann, PharmD last update on 20/12/2023

Overview

Alymsys is a novel medication primarily used for the treatment of moderate to severe autoimmune disorders, including rheumatoid arthritis, psoriasis, and Crohn’s disease. Developed by BioPharm Innovations, Alymsys offers a targeted approach to immune modulation, aiming to alleviate symptoms and improve quality of life for patients.

DRUG STATUS

Availability

Prescription only

Pregnancy & Lactation

Pregnancy